Bengaluru: For years, oral cancer in India has been viewed through the lens of male tobacco use, even though women in parts ...

The FDA has granted accelerated approval to sevabertinib (Hyrnuo) for the treatment of patients with locally advanced or metastatic, nonsquamous non–small cell lung cancer (NS-NSCLC) with HER2 ...

Drug approvals this year have reflected the trend in clinical development of biologics shifting from intravenous to ...

This discussion looks ahead at how the role of PD-1 inhibitors may continue to evolve in the treatment of esophageal squamous ...

This discussion provides a forward-looking discussion on how the role of PD-1 inhibitors may continue to evolve in the ...

Ficerafusp alfa 750mg QW in combination with pembrolizumab demonstrates overall response rate and safety profile consistent with the 1500mg QW ...